Mabwell(SH:688062) 2 1 Shi Ji Jing Ji Bao Dao·2025-08-04 11:17Core Viewpoint - Liu Datao, the chairman and general manager of Maiwei Biotech, received an administrative penalty from the China Securities Regulatory Commission (CSRC) for engaging in short-term trading of the company's stock, which is a violation of the Securities Law [2][3][5] Summary by Sections Administrative Penalty Details - The CSRC found that from January 18, 2022, to July 18, 2022, Liu Datao used a third-party securities account to buy a total of 976,567 shares of Maiwei Biotech, amounting to approximately 19.3 million yuan, and sold 634,265 shares for about 13.88 million yuan [2][3][4] - Liu's actions were classified as illegal under Article 44 and Article 189 of the Securities Law, which prohibits directors and senior management from selling company stock within six months of purchase [5] Penalty Imposed - Liu Datao was issued a warning and fined 600,000 yuan for his violations, with the requirement to pay the fine within 15 days of receiving the penalty notice [5][6] - The penalty is solely directed at Liu Datao and does not significantly impact the company's daily operations [2][6] Company Compliance and Disclosure - The company emphasizes its commitment to comply with relevant laws and regulations and has fulfilled its obligation for timely information disclosure regarding the incident [6][7]